SQUADRITO, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 11.495
NA - Nord America 9.892
AS - Asia 5.577
SA - Sud America 1.946
AF - Africa 186
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 29.108
Nazione #
US - Stati Uniti d'America 9.680
RU - Federazione Russa 5.998
SG - Singapore 2.197
CN - Cina 1.771
BR - Brasile 1.677
IE - Irlanda 1.365
SE - Svezia 1.214
IT - Italia 681
HK - Hong Kong 617
DE - Germania 579
UA - Ucraina 403
VN - Vietnam 325
FR - Francia 312
FI - Finlandia 291
GB - Regno Unito 218
IN - India 186
PL - Polonia 146
CA - Canada 102
AR - Argentina 90
BD - Bangladesh 63
BE - Belgio 56
TR - Turchia 55
MX - Messico 54
ZA - Sudafrica 52
IQ - Iraq 46
EC - Ecuador 45
ID - Indonesia 44
AT - Austria 42
JP - Giappone 41
ES - Italia 40
CO - Colombia 36
MA - Marocco 35
NL - Olanda 35
UZ - Uzbekistan 34
EE - Estonia 29
PK - Pakistan 27
CL - Cile 21
VE - Venezuela 21
LT - Lituania 19
PY - Paraguay 19
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 18
KE - Kenya 18
AE - Emirati Arabi Uniti 17
JO - Giordania 15
IL - Israele 14
JM - Giamaica 14
PE - Perù 14
EG - Egitto 13
UY - Uruguay 13
AZ - Azerbaigian 12
NP - Nepal 12
PH - Filippine 12
SA - Arabia Saudita 12
TN - Tunisia 12
IR - Iran 11
BO - Bolivia 10
KZ - Kazakistan 10
LB - Libano 10
DZ - Algeria 9
CR - Costa Rica 8
HN - Honduras 8
DO - Repubblica Dominicana 7
MY - Malesia 7
OM - Oman 7
PA - Panama 7
AL - Albania 6
PT - Portogallo 6
RO - Romania 6
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
AO - Angola 4
AU - Australia 4
CH - Svizzera 4
GT - Guatemala 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BW - Botswana 3
ET - Etiopia 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
QA - Qatar 3
SV - El Salvador 3
TG - Togo 3
EU - Europa 2
LY - Libia 2
NG - Nigeria 2
NO - Norvegia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 29.086
Città #
Ashburn 1.882
Moscow 1.774
Dublin 1.365
Dallas 1.297
Singapore 1.280
Chandler 958
Jacksonville 805
Nyköping 654
Hong Kong 617
Beijing 567
San Jose 503
The Dalles 268
Messina 241
Los Angeles 219
Princeton 201
Medford 189
Lauterbourg 180
Ann Arbor 163
Munich 163
Des Moines 153
Cambridge 150
New York 146
São Paulo 144
Warsaw 136
Boardman 123
Ho Chi Minh City 119
Dearborn 96
Buffalo 87
Tianjin 76
Guangzhou 75
Turku 71
Woodbridge 66
Hanoi 65
Nuremberg 64
Redondo Beach 64
Orem 62
Wilmington 62
Jinan 58
Brussels 56
Helsinki 56
Rome 54
Frankfurt am Main 51
Rio de Janeiro 50
Belo Horizonte 46
Houston 44
Shenyang 44
Nanjing 43
Hyderabad 42
Council Bluffs 41
Tokyo 41
Brooklyn 40
Hebei 40
Santa Clara 39
Ottawa 38
Pune 37
San Mateo 37
Chennai 36
Catania 35
Seattle 35
Bremen 34
Brasília 33
Chicago 32
Haikou 32
Phoenix 31
Porto Alegre 31
Shanghai 30
Stockholm 30
Lancaster 29
Tashkent 27
Montreal 26
Ningbo 26
San Francisco 26
Vienna 26
Zhengzhou 26
Jakarta 24
Johannesburg 24
Boston 23
Hangzhou 23
London 23
Baghdad 22
Denver 22
Nanchang 22
Shenzhen 22
Rosolini 21
Curitiba 20
Manchester 19
Mexico City 19
Abidjan 18
Campinas 18
Düsseldorf 18
Guarulhos 18
Mumbai 18
Taizhou 18
Amsterdam 17
Atlanta 17
Lappeenranta 17
Poplar 17
Changsha 16
Dhaka 16
Haiphong 16
Totale 16.995
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 378
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 352
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 268
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 265
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 265
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 264
Abnormal left ventricular global strain during exercise-test in young healthy smokers 259
Atrial fibrillation in patients with cirrhosis 246
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 236
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 228
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 215
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 214
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 213
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 210
Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension 208
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 208
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 204
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 201
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 201
Erectile dysfunction in compensated liver cirrhosis 198
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 197
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 192
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 191
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 191
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 189
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 189
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 188
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience 186
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 184
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 181
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 181
Cardiovascular effects of raloxifene hydrochloride 179
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 176
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 175
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 175
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury 171
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 170
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 169
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review 169
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 168
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 167
Clinical virology of hepatitis B virus infection 167
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 167
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 167
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 167
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 166
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 165
Alexithymia and asthma: a systematic review 165
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 164
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 162
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 161
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 160
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 160
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 159
Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension] 159
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 158
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate 157
Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock 156
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 156
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 156
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 156
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 155
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 155
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 154
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 154
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 153
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 151
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 151
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 150
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 149
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 149
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 148
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 148
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 148
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 148
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 148
Gene transfer of I kappa B alpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury 147
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 147
Effect of sulfatide on acute lung injury during endotoxemia in rats 146
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 145
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 145
Inhibition of tumour necrosis factor and reversal of endotoxin- induced shock by U-83836E, a 'second generation' lazaroid in rats 144
Prevalence of pulmonary hypertension in an unselected community-based population: A retrospective echocardiographic study-res-ph study 144
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 144
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 143
Natural course of COVID-19 and independent predictors of mortality 143
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 143
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 143
Machine learning to calculate heparin dose in COVID-19 patients with active cancer 142
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 141
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 141
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 140
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 140
Endocan and circulating progenitor cells in women with systemic sclerosis: Association with inflammation and pulmonary hypertension 140
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 140
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 140
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 139
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock 138
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing 138
Fever and rhomboid target lesion in decompensated cirrhosis 137
Totale 17.520
Categoria #
all - tutte 95.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 0 94 47
2021/20221.482 25 168 36 42 97 7 99 59 29 297 171 452
2022/20233.905 286 386 164 281 286 403 62 230 1.605 26 132 44
2023/20241.271 76 138 62 121 82 221 14 272 4 86 76 119
2024/20254.793 107 60 80 278 210 180 220 983 1.123 323 428 801
2025/202614.451 764 1.120 1.150 972 1.172 3.002 1.776 1.784 1.865 672 174 0
Totale 29.537